STIVARGA 40MG 3*28 F.C. TABS
سعر STIVARGA 40MG 3*28 F.C. TABS
17697.00 جنية
الشركة المنتجة لـ STIVARGA 40MG 3*28 F.C. TABS
BAYER HEALTHCARE
المادة الفعالة STIVARGA 40MG 3*28 F.C. TABS
REGORAFENIB
معلومات عن STIVARGA 40MG 3*28 F.C. TABS
Regorafenib is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.
INDICATIONS:
*Metastatic colorectal cancer.
*Advanced gastrointestinal stromal tumours.
